| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
MACF1 Blocking Peptide for STJ501645 is synthetically produced from the sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Specificity: |
This blocking peptide is recommended for use in combination with MACF1 antibody, STJ501645 |
| Immunogen: |
Recombinant protein |
| Background | F-actin bidning protein which may play a role in cross-linking actin to other cytoskeletal proteins and also binds microtubles. Acts as positive regulator of Wnt receptor signaling pathway and is invovled in translocation of AXIN12 and its associated complex from the cytoplasm to cell membrane. Has actin-regulated ATPase activity and is inovled in focal adhesios assembly and dynamics. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
